lobbying_activities: 1555830

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
1555830	a3cc922f-79ea-409d-a421-8ed011623d70	Q2	FTI GOVERNMENT AFFAIRS	401054971	AMERICAS HEALTH INSURANCE PLANS (AHIP)	2014	second_quarter	PHA	H.R. 460, Patients' Access to Treatments Act (McKinley) - cost sharing in a specialty drug tier. H.R. 1367, FEHBP Prescription Drug Integrity, Transparency, and Cost Savings Act (Lynch) - FEHBP prescription drugs. H.R. 3204, Drug Quality and Security Act (Upton) - drug safety issues. S. 214, Preserve Access to Affordable Generics Act (Klobuchar) - access to generic drugs.	HOUSE OF REPRESENTATIVES,SENATE	30000		0	0	2014-07-17T13:09:25.093000-04:00